CASR Recombinant monoclonal antibody, PBS Only

CASR Uni-rAb® Recombinant Antibody for WB, Indirect ELISA
Cat No. 86319-1-PBS
Clone No.243029B11

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse

Applications

WB, Indirect ELISA

Calcium Sensing Receptor, CAR, Extracellular calcium-sensing receptor, FHH, FIH

Formulation:  PBS Only
Conjugate:  Unconjugated
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Product Information

86319-1-PBS targets CASR in WB, Indirect ELISA applications and shows reactivity with human, mouse samples.

Tested Reactivity human, mouse
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Immunogen

Peptide

Predict reactive species
Full Name calcium-sensing receptor
Calculated Molecular Weight 121 kDa
Observed Molecular Weight120 kDa
GenBank Accession NumberNM_000388
Gene Symbol Calcium Sensing Receptor
Gene ID (NCBI) 846
Conjugate Unconjugated
FormLiquid
Purification MethodProtein A purification
UNIPROT IDP41180
Storage Buffer PBS only, pH 7.3.
Storage ConditionsStore at -80°C.

Background Information

CASR, also named as GPRC2A, PCAR1, belongs to the G-protein coupled receptor 3 family. Changes in extracellular calcium are thought to modulate a balance between proliferation and differentiation in a variety of cell types. The activity of CASR is mediated by a G-protein that activates a phosphatidylinositol-calcium second messenger system. It has been shown to play a major role in regulating parathyroid hormone secretion and subsequently influencing the calcium concentration of extracellular fluids. In normal primary keratinocytes and breast epithelial cells, proliferation is inhibited and elevated extracellular calcium levels trigger differentiation. Malignant transformations of these cell types are accompanied by a loss of responsiveness to the anti-proliferative effects of elevated extracellular calcium. Several disorders of calcium homeostasis have been linked to mutations in the CaSR. These include familial hypocalciuric hypercalcemia (FHH), neonatal severe hyperparathyroidism (NSHPT), and autosomal dominant hypocalemia (ADHypo).

Loading...
||
New chat Able
正在加载,请稍候...